Xin Lang Cai Jing·2025-10-31 02:37Core Insights - Haiprui (002399.SZ) reported its Q3 2025 results on October 31, 2025, highlighting significant institutional investor holdings [1] Institutional Holdings - As of October 30, 2025, seven institutional investors disclosed holding a total of 1 billion shares of Haiprui, representing 68.14% of the company's total equity [1] - The institutional investor group includes Shenzhen Lerun Technology Co., Ltd., Gongqingcheng Jintian Soil Investment Partnership (Limited Partnership), Gongqingcheng Water Droplet Stone Investment Partnership (Limited Partnership), Gongqingcheng Feilai Stone Investment Co., Ltd., Shenzhen Haiprui Pharmaceutical Co., Ltd. - Second Employee Stock Ownership Plan, Hong Kong Central Clearing Limited, and Shenzhen Haiprui Pharmaceutical Group Co., Ltd. - Third Employee Stock Ownership Plan [1] - Compared to the previous quarter, the total institutional holding percentage decreased by 0.44 percentage points [1] Public Fund Activity - In this period, 92 public funds were not disclosed compared to the previous quarter, including Southern CSI 1000 ETF, Huaxia CSI 1000 ETF, GF CSI 1000 ETF, GF CSI All-Index Medical and Health ETF, and Fortune CSI 1000 ETF [1] Foreign Investment - One foreign fund, Hong Kong Central Clearing Limited, increased its holdings compared to the previous period, with a slight increase in shareholding percentage [1]